LBA45 Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
| Autor: | Schadendorf, D., Gogas, H., Kandolf Sekulovic, L., Meier, F., Eigentler, T.K., Ziemer, M., Terheyden, P., Gesierich, A., Herbst, R., Kähler, K.C., Ziogas, D.C., Mijušković, Ž., Garzarolli, M., Garbe, C., Roesch, A., Ugurel-Becker, S., Gutzmer, R., Grob, J.J., Zimmer, L., Livingstone, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1235-S1236 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|